EMERGENT BIOSOLUTIONS
11.00
07-November-24 15:59:59
15 minutes delayed
Stocks
+1.80
+19.57%
Today's range
10.98 - 12.73
ISIN
N/A
Source
NYSE
-
Reverse the Silence Campaign Casts a National Spotlight on Overdose Risks Associated with Opioid Use
26 Jul 2021 09:01:00 By Nasdaq GlobeNewswire
-
15 Jul 2021 06:30:00 By Nasdaq GlobeNewswire
-
11 Jun 2021 16:35:24 By Nasdaq GlobeNewswire
-
26 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
06 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
05 May 2021 16:05:02 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results for First Quarter 2021
29 Apr 2021 16:05:02 By Nasdaq GlobeNewswire
-
Statement on Issuance of Form FDA 483 at Emergent Bayview Facility
21 Apr 2021 12:46:42 By Nasdaq GlobeNewswire
-
15 Apr 2021 06:30:00 By Nasdaq GlobeNewswire
-
04 Apr 2021 22:09:06 By Nasdaq GlobeNewswire
-
02 Apr 2021 08:00:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
01 Mar 2021 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2020
18 Feb 2021 16:05:01 By Nasdaq GlobeNewswire
-
04 Feb 2021 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
10 Jan 2021 14:00:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
04 Jan 2021 06:30:00 By Nasdaq GlobeNewswire